Difficulty Reaching Orgasm: The Real Causes (and Proven Ways to Improve It)

A medically informed guide to delayed ejaculation, anorgasmia, and reduced orgasmic intensity

(An educational health article — not a substitute for individual medical care)

Few subjects in men's health are surrounded by as much silence as difficulty reaching orgasm. A man will readily mention a sore knee or rising blood pressure to his doctor, yet a man who can no longer climax — or who climaxes only with great effort, or whose orgasm has lost its former intensity — often says nothing for months or years. That silence is unfortunate, because this is a common, well-recognised, and frequently treatable problem, particularly in men over 50, 60, and 70. Understanding it begins with clear language.

Clinicians group these complaints under the umbrella of male orgasmic and ejaculatory disorders, and the distinctions matter because they point toward different causes and treatments:

Delayed ejaculation (DE) — a persistent, distressing difficulty reaching ejaculation despite adequate desire, stimulation, and erection. The man wants to climax and is stimulated enough that he ordinarily would, yet the threshold is not crossed, or only after a very prolonged effort.

Anorgasmia — the perceived absence of orgasm despite adequate stimulation. The International Society for Sexual Medicine describes the related state of anorgasmic ejaculation as absence of the orgasmic sensation even when ejaculation physically occurs. Anorgasmia can be understood as the far end of the delayed-ejaculation spectrum, where climax cannot be reached at all.

Reduced orgasmic intensity, or "weak" orgasm — the man still climaxes, but the sensation is muted, briefer, or less pleasurable than before. This is among the most common age-related complaints and is frequently under-discussed in clinics focused mainly on erections.

Situational difficulty — a man may climax readily alone but struggle with a partner, or the reverse. The pattern is a powerful diagnostic clue. Difficulty that vanishes during solo stimulation usually points toward psychological, relational, or stimulation-mismatch factors rather than nerve or hormone damage, whereas difficulty in every context more often suggests an organic contributor.

It is essential to separate ejaculation from orgasm, because the two are related but not identical. Ejaculation is a largely mechanical, reflex-driven expulsion of fluid; orgasm is the brain's experience of climactic pleasure and release. They usually occur together, which is why men equate them, but they can be uncoupled. Some men experience a full, satisfying orgasm with little or no fluid — common after prostate surgery or with certain medications. Others ejaculate with diminished pleasure. Recognising this separation is reassuring: a reduced or "dry" ejaculate does not necessarily mean the end of orgasmic pleasure, and orgasm may remain achievable even when ejaculation is altered or absent.

Finally, normal age-related change must be distinguished from clinically significant dysfunction. It is entirely normal for an older man to need more time, more direct stimulation, and stronger arousal to climax. This becomes a disorder only when the difficulty is persistent and causes genuine distress to the man or his partner. Needing twenty minutes instead of five is a change in tempo, not a disease. The clinical question is always: is this bothering you?

How common is it?

Estimates vary because definitions differ, but population data are instructive. The Global Study of Sexual Attitudes and Behaviors (Laumann and colleagues) found that roughly one in ten men reported orgasmic difficulty, with the odds rising steeply with age. Reviews in sexual medicine consistently describe delayed ejaculation as the least common but among the most distressing of the male sexual dysfunctions, with lifelong forms near one percent and acquired forms around four percent, and higher figures in older and medically complex men. In short: if you are an older man struggling to climax, you are far from alone.

To understand why orgasm can fail, it helps to appreciate how elaborate the normal process is. Orgasm is not a "penis problem" in any simple sense. It is the coordinated output of the brain, the spinal cord, the autonomic and somatic nerves, the hormonal system, the blood vessels, the pelvic floor muscles, the prostate and seminal structures, and — layered over all of this — a man's psychology and his relationship. A weakness anywhere along this chain can blunt or block the result.

From desire to climax

Arousal begins in the brain. Erotic thoughts, touch, sight, and memory converge on regions such as the medial preoptic area of the hypothalamus, the medial amygdala, and the mesolimbic reward circuits. Here the neurotransmitter dopamine plays a central, facilitating role — it is the chemistry of wanting, motivation, and reward. Animal and human work summarised by Hull and colleagues, and by Giuliano and Clément in their reviews of ejaculatory neurophysiology, shows that dopamine lowers the ejaculatory threshold and drives sexual motivation, while serotonin acts largely as a brake. This dopamine–serotonin balance is the single most important concept for understanding many medication effects, as later sections show.

As arousal builds, the parasympathetic nervous system drives erection by releasing nitric oxide, which relaxes the smooth muscle of the penile arteries and erectile bodies so they engorge with blood. Sensory feedback from the penis — especially the glans — travels up the pudendal nerve to the spinal cord and brain, reinforcing arousal in a rising loop. Skin, brain, and spinal cord are in constant conversation.

Ejaculation itself is fundamentally a spinal reflex. Researchers have identified a cluster of neurons in the lumbar spinal cord — the spinal ejaculation generator — that integrates excitatory and inhibitory signals from the genitals and the brain and, once a threshold is crossed, fires in a coordinated burst. This unfolds in two phases. In the emission phase, sympathetic nerves prompt the seminal vesicles, prostate, and vas deferens to deposit fluid into the urethra and close the bladder neck. In the expulsion phase, rhythmic contractions of the pelvic floor muscles — chiefly the bulbospongiosus and ischiocavernosus — propel semen outward. It is these rhythmic contractions that a man feels as the physical pulse of orgasm, which is one reason pelvic floor conditioning matters.

Riding on top of this mechanical reflex is the neurochemical experience of orgasm. At climax the brain releases a surge of chemicals including oxytocin and, shortly afterward, prolactin. Oxytocin appears to facilitate the ejaculatory reflex and contributes to the sense of bonding and release; experimental work has traced oxytocin projections from the hypothalamus down to the spinal ejaculation generator. The post-orgasmic rise in prolactin is thought to contribute to the refractory period — the temporary drop in desire and inability to climax again immediately — and chronically elevated prolactin is a recognised cause of low desire and orgasmic difficulty.

Hormones set the background tone. Testosterone supports libido, the responsiveness of genital tissues, and the drive that initiates the whole sequence; analyses of the European Male Ageing Study link declining testosterone with falling sexual desire. Thyroid hormones influence the speed of the system, with both overactive and underactive thyroid associated with ejaculatory problems. The take-home message is that orgasm is a whole-body, whole-person event — brain, nerves, hormones, circulation, muscle, and mind acting together.

Why does climax so often become harder with age? Because virtually every component of the orgasm pathway changes gradually over the decades. None of these changes individually spells the end of pleasure, but together they explain why an older man may need a different strategy.

Penile sensitivity declines. The density and responsiveness of sensory nerve endings in the genitals fall with age, and nerve conduction slows. The same touch that once produced a sharp signal now produces a softer one, so more direct and sustained stimulation is needed to reach the same threshold. Vascular changes compound this: the arterial relaxation that underlies a firm erection and full glans engorgement becomes less efficient, and reduced engorgement means reduced sensory feedback.

Hormonally, testosterone declines slowly from midlife, which can dampen desire and the intensity of the drive toward climax. The pelvic floor muscles that power the rhythmic contractions of orgasm tend to weaken with age and inactivity, which can translate into a less forceful, less intense climax and a lower-volume ejaculate. Prostate and seminal vesicle changes, including the near-universal benign prostatic enlargement of later life and the treatments used for it, alter the mechanics of emission and can reduce or redirect the ejaculate.

Arousal also becomes slower and more dependent on context. The spontaneous, almost reflexive arousal of youth gives way to a system that needs more deliberate, direct, physical stimulation — and more time. Psychological factors such as reduced novelty, long-established relationships, and the accumulated weight of stress and worry can lower the intensity of desire. On top of this, the burden of chronic illness and the medications used to treat it grows with each decade, and these are frequently the decisive factors.

The constructive way to read all this is not as decline but as a change in requirements. The older body asks for more arousal, more direct stimulation, more time, and a healthier overall physiology. Men who adapt their approach, rather than trying to force the old pattern, very often continue to enjoy satisfying orgasms well into later life.

When difficulty reaching orgasm is acquired — that is, when a man who previously climaxed normally finds it has become hard or impossible — an organic medical cause should always be considered, especially in older men. The conditions below affect orgasm through one or more shared mechanisms: damaged or slowed nerve signalling, impaired blood flow, disturbed hormones, low mood and motivation, reduced genital sensation, poor stamina, or disrupted pelvic anatomy.

Nerve and neurological conditions

Because ejaculation and orgasm depend on intact nerve pathways, any disease that damages nerves can interfere. Diabetes is the most important example: over years, high blood sugar damages peripheral and autonomic nerves (diabetic neuropathy), and studies of diabetic men report delayed ejaculation in roughly a third and retrograde ejaculation in around a fifth, along with reduced genital sensation and orgasmic difficulty. Other peripheral neuropathies — from alcohol, chemotherapy, or vitamin deficiency — act similarly. Conditions of the central nervous system, including multiple sclerosis, Parkinson's disease, stroke, and spinal cord injury or disease, can all impair the brain-and-spinal-cord circuitry that drives climax, with the pattern depending on the location and extent of the damage.

Hormonal and endocrine conditions

Low testosterone reduces desire and can blunt orgasm. Thyroid disease in either direction is linked to ejaculatory problems; a multicentre study by Carani and colleagues found high rates of ejaculatory dysfunction in both hypothyroid and hyperthyroid men that improved with treatment. Elevated prolactin — from a pituitary tumour, certain drugs, or other causes — suppresses desire and orgasmic capacity and warrants specific testing when suspected.

Cardiovascular and metabolic conditions

Heart and vascular disease, high blood pressure, metabolic syndrome, and obesity all impair the blood flow and endothelial (blood-vessel-lining) health on which genital engorgement and sensation depend, and they frequently travel together with diabetes and low testosterone. Because the penile arteries are small, sexual symptoms are sometimes an early warning of wider cardiovascular disease — a reason these complaints deserve attention rather than embarrassment.

Whole-body illness, mood, and pelvic conditions

Chronic kidney disease, liver disease, chronic pain, and obstructive sleep apnoea all sap energy, disturb hormones, and reduce sexual function. Depression and anxiety deserve particular emphasis: they reduce desire and orgasmic capacity directly, and the medications used to treat them are themselves common culprits (see Section 5). Locally, pelvic and prostate surgery, radiation therapy, Peyronie's disease (curvature from scar tissue), erectile dysfunction, reduced penile sensitivity, and chronic prostatitis or chronic pelvic pain syndrome can each interfere with the mechanics, comfort, and sensation of climax. Erectile dysfunction is especially important because a man who cannot reliably reach or sustain full arousal often cannot reach the orgasmic threshold either; treating the erection sometimes restores the orgasm.

A note on prostate procedures: after radical prostatectomy, the prostate and seminal vesicles are removed, so ejaculation becomes "dry," yet many men still experience orgasm. After common procedures for benign enlargement such as TURP, retrograde ejaculation (semen passing backward into the bladder) is frequent, again usually with preserved orgasmic sensation. This underscores the central principle that orgasm and ejaculation are separable.

Medications are among the most common — and most reversible — causes of delayed or absent orgasm, which is why a careful medication review is one of the first steps in evaluation. The timing is the giveaway: when orgasmic difficulty begins within weeks of starting or increasing a drug, that drug is the prime suspect.

The leading offenders are the serotonergic antidepressants. Selective serotonin reuptake inhibitors (SSRIs) raise serotonin tone, and because serotonin is the brake on the ejaculatory reflex, SSRIs reliably delay or block orgasm. This effect is so consistent that the same drugs are used deliberately, off-label, to treat premature ejaculation. Reported rates of SSRI-associated sexual dysfunction range widely — from roughly a quarter to as high as 80 percent of users depending on the drug and how it is measured — with paroxetine often cited among the most likely to cause delayed ejaculation. Serotonin–noradrenaline reuptake inhibitors (SNRIs) and the older tricyclic antidepressants can do the same. In a minority of people, sexual side effects persist after the drug is stopped, a controversial entity termed post-SSRI sexual dysfunction that is now the subject of active review in the sexual-medicine literature.

Other drug classes contribute too. Antipsychotics, particularly those that raise prolactin, can suppress orgasm; benzodiazepines and opioids blunt the nervous system and reduce sexual response, with chronic opioids also lowering testosterone. The 5-alpha-reductase inhibitors finasteride and dutasteride, used for hair loss and prostate enlargement, are associated with reduced libido and ejaculatory problems in some men. Several blood-pressure medications, especially older beta-blockers and certain diuretics, can impair sexual function, and some prostate (alpha-blocker) medications cause reduced or retrograde ejaculation. Alcohol in excess and various recreational substances are frequently overlooked contributors, as are any medications that suppress testosterone or raise prolactin.

An important safety point: no one should stop a prescribed medication abruptly on the basis of an article. Antidepressants in particular can cause withdrawal effects and a return of the underlying illness if stopped suddenly. The right move is a conversation with the prescriber, who has several options — adjusting the dose, changing the timing, switching to a drug with a lower sexual-side-effect profile, or in some cases adding a second agent under supervision. These decisions must be individualised and medically supervised.

A focused set of blood tests can uncover treatable contributors and reassure the man about what is not the problem. The aim is not to test everything indiscriminately, but to test thoughtfully based on the history. The following are commonly considered.

Hormonal panel. Total testosterone is the starting point and should be drawn in the morning, when levels peak, and confirmed with a repeat test if low, because a single low reading is unreliable. Free testosterone and sex hormone–binding globulin (SHBG) help interpret borderline results, particularly in older or obese men in whom SHBG is often abnormal. Luteinising hormone (LH) and follicle-stimulating hormone (FSH) help distinguish a testicular cause from a pituitary one. Prolactin should be checked when desire and orgasm are both reduced, since a high level points toward a pituitary cause and is specifically treatable. Estradiol is sometimes measured because both very high and very low levels can disturb function. The European Male Ageing Study helped define the testosterone thresholds at which sexual symptoms become more likely, which is why interpretation is always clinical rather than a simple number on a page.

Metabolic and thyroid tests. Thyroid-stimulating hormone (TSH), with free T4 if needed, screens for thyroid disease. Fasting glucose and HbA1c screen for diabetes and prediabetes — a frequent and important finding — with fasting insulin added when insulin resistance is suspected. A lipid profile gauges cardiovascular risk that often parallels sexual symptoms.

General health and nutrition. Vitamin B12 (deficiency can cause neuropathy), vitamin D, a complete blood count (CBC, to detect anaemia), and a comprehensive metabolic panel covering liver and kidney function round out the picture. A PSA (prostate-specific antigen) test is considered when age-appropriate and clinically indicated, particularly before any testosterone therapy.

Abnormal results help explain the symptoms and direct treatment. Low testosterone may underlie reduced desire, fatigue, weaker erections, and blunted orgasm; high prolactin can do the same and demands its own work-up; thyroid disturbance can speed up or slow down the whole system; raised glucose flags neuropathy and vascular risk; B12 deficiency points to a nerve cause; and anaemia or organ dysfunction can sap overall vitality. Crucially, fixing a confirmed abnormality (for example, correcting genuine testosterone deficiency in a symptomatic man) is one of the more rewarding interventions in this field.

The mind can block orgasm even when the body is mechanically capable. This is not a sign of weakness or a lack of love; it is simply how the nervous system works. Climax requires a degree of mental surrender, and anxiety is its enemy. The clearest clue that psychological factors are at play is situational difficulty — a man who climaxes easily alone but not with a partner almost certainly has a working body and a worried mind.

Several patterns recur in clinical practice. Performance anxiety and the felt pressure to climax create a self-defeating loop: the harder a man tries, the more he activates the stress (sympathetic) response that opposes relaxed arousal. Fear of disappointing a partner, guilt, shame, unresolved relationship resentment, and a lack of emotional safety all pull attention away from pleasure. Depression and chronic stress flatten desire and the capacity for reward. A history of trauma can make full surrender feel unsafe. The loss of novelty in long relationships can lower arousal intensity. And the simple absence of relaxed, unhurried conditions can be enough to keep a man below his threshold.

A particularly useful concept from sex therapy is spectatoring — a term from Masters and Johnson describing the habit of mentally stepping outside the experience to monitor and judge one's own performance, rather than staying immersed in sensation. The spectator in the head is the opposite of the relaxed attention orgasm requires. Much of psychological treatment is, in essence, about coaxing a man back inside his own body and out of the anxious commentary.

The therapeutic principle that follows is counterintuitive but reliable: trying harder usually makes orgasm harder. Reducing the pressure — removing climax as the goal, allowing sex to be pleasurable without a required endpoint, and rebuilding relaxed, sensory focus — is often what finally allows climax to return. This is why a calm conversation with a partner, and sometimes the help of a sex therapist, can be more effective than any pill.

One of the most common and most fixable causes of partnered orgasmic difficulty is a mismatch between the stimulation a man's body has been trained to expect and the stimulation a partner can realistically provide. Over years or decades, solo habits can condition the nervous system to a very specific pattern, and partnered sex simply does not match it.

The usual culprits are well described in the sexual-medicine literature on "idiosyncratic" masturbation. They include a very firm grip that no partner's body can replicate; very fast, high-friction stimulation; dependence on one precise rhythm; reliance on a very particular fantasy or on pornography to reach the necessary level of arousal; and, over time, a reduced sensitivity to the gentler, more variable stimulation of partnered sex. The signature pattern is a man who climaxes readily and quickly alone but cannot reach the threshold with a partner.

The good news is that the nervous system can be retrained, gradually and without shame. The general principles, applied patiently over weeks, are to reduce grip pressure, to slow down, to introduce lubrication so that lighter touch becomes sufficient, to deliberately vary rhythm and technique, and to step back from extreme or highly specific stimulation so that the body relearns to respond to a broader range of input. Crucially, this retraining should never be framed as punishment or as evidence of a moral failing. It is simply recalibration, much like easing off an overly strong pair of glasses so the eyes can readjust. Patience and self-compassion are part of the treatment.

Because the physical pulse of orgasm is produced by rhythmic contractions of the pelvic floor muscles, the condition of those muscles directly affects how easily and how intensely a man climaxes. Two opposite problems can occur, and they call for opposite solutions.

The first is weakness and poor coordination. Pelvic floor muscles that are weak, or that a man cannot consciously engage (a poor "mind–muscle connection"), produce feebler orgasmic contractions and a less intense climax. Chronic sitting, inactivity, poor hip mobility, and weak glutes and core all contribute. A growing evidence base supports pelvic floor muscle training here: systematic reviews of pelvic floor physiotherapy for male sexual dysfunction (including work reviewed in Sexual Medicine Reviews and the International Journal of Impotence Research) report improvements in erectile function and ejaculatory control, and some men report stronger, more satisfying orgasms.

The second, less obvious problem is the opposite: an overactive, chronically tense pelvic floor. Muscles that are clenched and cannot relax can cause pelvic pain, urinary urgency, and paradoxically impaired orgasm, because the rhythmic release of climax requires muscles that can let go. For these men, more Kegels are exactly the wrong prescription; what they need is relaxation, stretching, and "reverse Kegels" (a gentle bearing-down or letting-go rather than a squeeze). This distinction is important enough that men with pelvic pain or tension should ideally be assessed by a pelvic floor physical therapist before starting a strengthening programme.

A practical, well-rounded programme might include:

• Correct Kegels — a genuine contraction of the muscles used to stop the flow of urine or prevent passing wind, held briefly and then fully released, without clenching the buttocks or holding the breath.

• Reverse Kegels and relaxation — for men with tension, a gentle, conscious letting-go and lengthening of the pelvic floor.

• Diaphragmatic (belly) breathing — to down-regulate the nervous system and release pelvic tension.

• Hip and glute work — glute bridges, squats, and hip-mobility exercises that support the pelvis and improve local circulation.

• General conditioning — regular walking, resistance training, and cardiovascular exercise, which improve blood flow, testosterone, insulin sensitivity, and confidence.

• Pelvic floor physical therapy — specialist assessment for men who are unsure whether they need to strengthen or to relax, or who have pain, urgency, or post-surgical changes.

Men who have received a penile implant — and particularly a malleable (semi-rigid) implant — deserve a clear and careful discussion, because expectations around orgasm are often misunderstood. The single most important fact is this: a penile implant restores rigidity, but it does not, by itself, create orgasm. Implants are designed to treat erectile dysfunction; they place rods or inflatable cylinders inside the erectile bodies so a man can have intercourse. They do not change the nerves, hormones, brain pathways, or pelvic muscles that actually produce orgasm. Reputable sources are explicit that an implant does not, in itself, alter sensation, the ability to orgasm, or ejaculation, which depend on factors the device does not touch.

In practice, this means orgasmic capacity after implantation usually reflects what it was before surgery, modified by the man's age, medications, hormones, and any nerve or prostate issues. A man who could orgasm before will generally still be able to; a man who already had orgasmic difficulty from diabetes or low testosterone will still have that difficulty, because the implant does not address it. Satisfaction studies of penile prostheses report very high overall satisfaction with rigidity and the ability to have intercourse — often above 90 percent — but some report comparatively lower satisfaction specifically with the orgasm experience, and satisfaction tends to be somewhat higher with inflatable than with malleable devices.

After surgery, several things can genuinely change the orgasm experience, and acknowledging them is part of good care. Sensation may feel different at first. Scar tissue, altered body image, anxiety or fear about the device, post-operative pain, reduced engorgement of the glans (which the implant does not fill), and changed mechanics of stimulation can all play a role. A malleable implant in particular keeps the penis permanently firm and changes the mechanics of sex compared with a natural erection or an inflatable device, so the familiar pattern of stimulation may need to be relearned. It is also worth repeating that orgasm may remain possible even when ejaculation volume is reduced or absent, depending on the man's prostate-surgery history, medications, and age.

Strategies that may help men with implants regain or improve orgasm include:

• More direct stimulation of the glans, which the implant does not engorge and which may need focused attention.

• A longer, unhurried warm-up to build full arousal before and during intercourse.

• Generous use of lubrication and experimentation with positions that reduce pressure or discomfort.

• Pelvic floor rehabilitation to strengthen the muscles of climax.

• Evaluation and treatment of low testosterone if it is medically confirmed.

• Addressing anxiety, body-image concerns, or fear surrounding the device, with a sex therapist where helpful.

• Prompt review by the implanting urologist if there is new or severe pain, signs of infection, erosion, or a sense that the device is malpositioned — these require medical assessment, not self-management.

No honest discussion can promise a specific result. The right approach is individualised: identify what is treatable, set realistic expectations, and work with both a urologist and, where appropriate, a sex therapist. If sensation has clearly changed after surgery, that is a reason to talk to the urologist, not to give up.

Because orgasm depends so heavily on healthy circulation, nerves, and hormones, the everyday habits that protect those systems also protect sexual function. The evidence here is strongest for cardiovascular and metabolic health, and it is encouraging: the same measures that protect the heart tend to protect sexual function.

A Mediterranean-style diet — rich in vegetables, fruit, legumes, whole grains, fish, nuts, and olive oil, with limited red and processed meat — has the best supporting evidence. A systematic review and meta-analysis found greater adherence to this pattern associated with better erectile function, and a narrative review in 2024 concluded that the Mediterranean diet can partially improve sexual dysfunction in men with metabolic syndrome through its anti-inflammatory, antioxidant, and blood-vessel-supporting effects. Randomised work in men with metabolic syndrome has shown improvements in erectile and endothelial function and reduced vascular inflammation over time.

Within that framework, several specifics are worth attention. Adequate protein and omega-3-rich foods (oily fish) support muscle and vascular health. Foods that support the body's nitric-oxide pathway — beetroot, leafy greens, watermelon, and pomegranate — are often highlighted for circulation, though they are a supporting cast, not a cure. Good hydration, reduced excess alcohol, and stopping smoking and nicotine all matter, because alcohol blunts the nervous system and tobacco damages the small blood vessels the genitals rely on. Weight loss when needed, control of blood sugar, and improved cardiovascular fitness can meaningfully improve testosterone, sensation, and stamina. Resistance training deserves a special mention for its benefits to testosterone, insulin sensitivity, and confidence.

A word of caution on supplements: the marketplace is full of exaggerated claims, and most over-the-counter "sexual enhancement" products lack good evidence and are sometimes adulterated. There is no magic capsule. The genuinely effective lifestyle interventions are the unglamorous ones — diet, exercise, sleep, and moderation — pursued consistently.

Because difficulty reaching orgasm is almost always multifactorial, the most effective approach is to match solutions to the causes identified during evaluation rather than to chase a single fix. The following is a practical map, organised by where the problem lies.

If a medication or substance is implicated: review every drug with the prescriber. Options include dose adjustment, timing changes, switching to an agent with fewer sexual side effects, or a supervised add-on strategy. Reduce alcohol and review recreational substances. Never stop prescribed medication abruptly on your own.

If hormones are abnormal: treat confirmed testosterone deficiency in a symptomatic man, manage thyroid disease, and investigate and treat elevated prolactin. These corrections can restore desire, energy, and orgasmic capacity.

If a medical condition is driving it: optimise diabetes control to limit further nerve damage, treat depression and anxiety (including with non-drug therapies), and treat erectile dysfunction, since restoring reliable arousal sometimes restores the orgasmic threshold.

If the cause is muscular or physical: undertake pelvic floor therapy — strengthening for weakness, relaxation for tension — alongside general conditioning and exercise.

If the cause is psychological, relational, or a stimulation mismatch: sex therapy, improved partner communication, a longer arousal phase, more direct stimulation, generous lubrication, mindfulness and sensory-focus techniques, and a deliberate reduction of climax pressure are the cornerstones. Carefully chosen vibratory stimulation can be useful for men whose sensory threshold has risen, and is sometimes recommended by clinicians for exactly this purpose.

Physicians sometimes consider specific medications to assist orgasm — for example, agents that shift the dopamine–serotonin balance or address elevated prolactin. It is important to be honest that the evidence for drug treatment of delayed ejaculation and anorgasmia is limited; reviews in this area conclude that there is no reliably effective, approved pharmacotherapy, and that treatment still rests mainly on identifying and addressing the underlying causes. Any such medication should be used only under medical supervision, with realistic expectations.

Underlying all of this are the universal supports: physical exercise, good sleep, and stress management, which improve nearly every contributing factor at once.

While much of this article is reassuring, certain features mean a man should seek medical evaluation promptly rather than waiting. These are signals that something specific and potentially serious may be going on:

• A sudden loss of orgasm or ejaculation, especially if it appeared abruptly.

• New numbness or loss of sensation in the penis, genitals, or the saddle region between the legs.

• New pelvic, perineal, or genital pain, or pain with orgasm.

• Blood in the urine or the semen.

• New or severe erectile dysfunction, which can be an early warning of cardiovascular disease.

• New symptoms appearing after pelvic, prostate, or other surgery, or after a penile implant.

• Neurological symptoms such as weakness, numbness elsewhere, balance or bladder changes, or visual disturbance.

• Very low libido, marked fatigue, or loss of muscle, which can point to low testosterone or other endocrine problems.

• Breast tenderness or any nipple discharge, which can suggest elevated prolactin and warrants specific testing.

• Symptoms that began soon after starting or changing a medication.

• Symptoms of diabetes such as excessive thirst, frequent urination, or unexplained weight change.

Seeing a doctor about these is not an overreaction. Many of the underlying causes are treatable, and some — such as a prolactin-secreting pituitary tumour, undiagnosed diabetes, or cardiovascular disease — are far better caught early.

The recommendations in this article rest on a substantial and growing body of research in sexual medicine, urology, and endocrinology. A few research areas are worth highlighting, both to show where the evidence is strong and to be honest about where it is still developing.

The neurophysiology of ejaculation and orgasm — the spinal ejaculation generator, the facilitating role of dopamine, the inhibitory role of serotonin, and the contributions of oxytocin and prolactin — has been mapped in detail through animal models and human imaging, summarised in reviews such as Giuliano and Clément's work on the central control of ejaculation and Hull and colleagues' work on dopamine and serotonin in male sexual behaviour. This basic science is what makes sense of clinical observations, especially around medications.

SSRI-induced sexual dysfunction is one of the best-documented drug effects in psychiatry, with a large literature on its frequency, mechanism, and management, and an active, more contested literature on persistent post-SSRI sexual dysfunction. The relationship between testosterone and male sexual desire has been quantified in large cohorts, most notably the European Male Ageing Study, and informs the Endocrine Society's clinical practice guideline on testosterone therapy in hypogonadism and the recommendations of the Fifth International Consultation on Sexual Medicine (ICSM 2024). Diabetic neuropathy and sexual function, including delayed and retrograde ejaculation, is well characterised in the urological literature. Pelvic floor physiotherapy for male sexual dysfunction has accumulated randomised trials and systematic reviews, reported in journals such as Sexual Medicine Reviews and the International Journal of Impotence Research. Penile prosthesis satisfaction and sexual-function outcomes are described in long-term satisfaction studies. And the broader question of aging and orgasmic function, along with focused reviews of delayed ejaculation and anorgasmia, appears across the Journal of Sexual Medicine, Sexual Medicine Reviews, European Urology, Urology, and Fertility and Sterility.

It is equally important to state the limits honestly. Delayed ejaculation and anorgasmia are the least studied of the male sexual dysfunctions; definitions vary between studies, prevalence figures are uncertain, and there is no single proven, approved drug treatment. This is precisely why a careful, individualised, multifactorial approach — rather than a one-size-fits-all pill — remains the standard of good care. A selection of relevant sources is listed at the end of this article for readers who wish to explore further.

If there is a single message to carry away, it is that difficulty reaching orgasm is almost never one problem with one cause. It is usually several smaller factors stacked together — a touch of nerve slowing from age or diabetes, a medication that raises the threshold, a testosterone level that has drifted down, a pelvic floor that has grown weak from years of sitting, a stimulation pattern that no longer matches a partner's, and a layer of anxiety quietly making all of it worse. Seen one at a time, each factor is modest. Seen together, they explain why climax has become hard. And seen as a list of treatable contributors, they explain why so many men improve.

That is the genuinely hopeful part. Once the right causes are identified, the great majority of men can make real progress with the right combination of measures: a thorough medical evaluation and the correction of any hormonal or metabolic problem; a careful medication review; treatment of erectile dysfunction, mood disorders, and chronic conditions; pelvic floor work and general physical conditioning; sensible lifestyle change; patient retraining of stimulation patterns; and, often most powerful of all, better communication with a partner and a deliberate easing of the pressure to perform. Aging changes the requirements for pleasure; it does not end it.

Men who struggle here are not broken, and they are not alone. The single most useful step is also the simplest: to break the silence and speak to a qualified healthcare professional. From there, the path forward is usually clearer, kinder, and more effective than years of quiet worry would ever suggest.

Love Emma

Medical disclaimer: This article is for general education only. It does not diagnose any individual and is not a substitute for personalised medical advice. The causes of difficulty reaching orgasm are individual and sometimes serious, and treatment must be tailored to the person. Anyone experiencing these symptoms — and especially anyone with the red-flag features described above — should consult a qualified healthcare professional (such as a family doctor, urologist, endocrinologist, or sex therapist) for proper assessment and treatment. Do not start or stop any medication on the basis of this article without medical advice.

SELECTED REFERENCES AND FURTHER READING

The following sources informed this article and are offered for readers who wish to explore the evidence in more depth. Where exact citation details may vary by edition or version, the source is described by its journal and topic rather than a fabricated reference.

1. Laumann EO, Nicolosi A, Glasser DB, et al. Sexual problems among women and men aged 40–80 years: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. International Journal of Impotence Research, 2005.

2. Shin DH, Spitz A. The evaluation and treatment of delayed ejaculation. Sexual Medicine Reviews, 2014;2:121–133.

3. Abdel-Hamid IA, Ali OI. Delayed ejaculation: pathophysiology, diagnosis, and treatment. World Journal of Men's Health (review).

4. Di Sante S, Mollaioli D, Gravina GL, et al. Epidemiology of delayed ejaculation. Translational Andrology and Urology (review).

5. Giuliano F, Clément P. Physiology of ejaculation: emphasis on serotonergic control. European Urology, 2005;48:408–417.

6. Giuliano F, Clément P. Central neurophysiology and dopaminergic control of ejaculation. Neuroscience and Biobehavioral Reviews, 2007.

7. Hull EM, Muschamp JW, Sato S. Dopamine and serotonin: influences on male sexual behavior. Physiology & Behavior, 2004;83:291–307.

8. Clément P, Giuliano F, and colleagues. Oxytocin and the spinal ejaculation generator (experimental studies in rodents).

9. Carani C, Isidori AM, Granata A, et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. Journal of Clinical Endocrinology & Metabolism, 2005;90:6472–6479.

10. Buvat J. Hyperprolactinemia and sexual function in men: a short review. International Journal of Impotence Research, 2003;15:373–377.

11. Wu FCW, Tajar A, Beynon JM, et al. (EMAS Group). Identification of late-onset hypogonadism in middle-aged and elderly men. New England Journal of Medicine, 2010;363:123–135.

12. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 2018;103:1715–1744.

13. Corona G, et al. Hormonal regulation of men's sexual desire, arousal, and erection: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024). Sexual Medicine Reviews, 2025.

14. Snyder PJ, et al. The Testosterone Trials: effects of testosterone treatment in older men. New England Journal of Medicine, 2016.

15. Montejo AL, Llorca G, Izquierdo JA, et al. Incidence of SSRI-associated sexual dysfunction. (Reviewed in J Clin Psychiatry and elsewhere.)

16. Healy D, et al. Post-SSRI sexual dysfunction: a literature review. Sexual Medicine Reviews, 2017.

17. Waldinger MD. The neurobiological approach to ejaculation and SSRI-induced delay (body of work on serotonergic effects on ejaculation).

18. Gray M, Zillioux J, Khourdaji I, Smith RP. Contemporary management of ejaculatory dysfunction. Translational Andrology and Urology (review).

19. Prostate Cancer Foundation. Anejaculation after prostate cancer treatment (patient and clinical resource).

20. Martin-Tuite P, Shindel AW. Management options for premature ejaculation and delayed ejaculation in men. Sexual Medicine Reviews, 2020;8:473–485.

21. Myers C, Smith M. Pelvic floor muscle training improves erectile dysfunction and premature ejaculation: a systematic review. Physiotherapy, 2019.

22. Cohen D, Gonzalez J, Goldstein I. The role of pelvic floor muscles in male sexual dysfunction and pelvic pain. Sexual Medicine Reviews, 2016;4:53–62.

23. Pelvic physical therapy for male sexual disorders: a narrative review. International Journal of Impotence Research, 2025.

24. Dorey G. Pelvic floor exercises for erectile dysfunction. BJU International, 2005.

25. Trost LW, Munarriz R, et al. Penile prosthesis outcomes and satisfaction (long-term satisfaction studies in prosthetic urology).

26. Esposito K, Giugliano D, et al. Mediterranean diet and erectile / endothelial function in men with metabolic syndrome (randomised and observational studies).

27. Influence of the Mediterranean diet on sexual function in people with metabolic syndrome: a narrative review. Nutrients, 2024;16:3397.

28. Association between improved erectile function and dietary patterns: a systematic review and meta-analysis (2024–2025).

29. American Urological Association (AUA) and European Association of Urology (EAU) guidance on sexual dysfunction and ejaculatory disorders (clinical guidelines).

30. Society for Endocrinology. Position statement on male hypogonadism and ageing, 2018.